Virtu Financial’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,175
Closed -$340K 1769
2025
Q3
$340K Buy
+2,175
New +$345K 0.02% 695
2024
Q4
Sell
-3,051
Closed -$601K 1623
2024
Q3
$601K Buy
+3,051
New +$634K 0.03% 394
2023
Q1
Sell
-1,568
Closed -$342K 1607
2022
Q4
$342K Buy
+1,568
New +$342K 0.05% 434
2022
Q3
Sell
-5,573
Closed -$1.19M 1802
2022
Q2
$1.19M Buy
+5,573
New +$1.36M 0.1% 188
2022
Q1
Sell
-722
Closed -$272K 1585
2021
Q4
$272K Buy
+722
New +$281K 0.03% 678
2021
Q3
Sell
-1,301
Closed -$481K 1579
2021
Q2
$481K Sell
1,301
-729
-36% -$243K 0.05% 498
2021
Q1
$588K Buy
2,030
+667
+49% +$185K 0.04% 445
2020
Q4
$341K Buy
+1,363
New +$325K 0.04% 584
2019
Q4
Sell
-2,455
Closed -$325K 1498
2019
Q3
$325K Sell
2,455
-1,143
-32% -$153K 0.03% 707
2019
Q2
$511K Buy
+3,598
New +$488K 0.03% 524
2015
Q3
Sell
-3,484
Closed -$245K 325
2015
Q2
$245K Buy
+3,484
New +$258K 0.02% 273

Other funds holding CRL

Virtu Financial's CRL Position: Q4 2025 in Review

Virtu Financial sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 2,175 shares — an estimated $340K sold.

Virtu Financial first reported a position in CRL in Q2 2015 and held it in 11 quarters. The position peaked at $1.19M in Q2 2022. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Virtu Financial reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 2,175 Charles River Laboratories shares in Q4 2025, an estimated $340K.
  • Virtu Financial first reported a position in Charles River Laboratories in Q2 2015 and held it in 11 quarters.
  • Virtu Financial's Charles River Laboratories position peaked at $1.19M in Q2 2022.
  • 580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.